Clinical Kidney Journal

Article	Citations
Prolonged normothermic perfusion: a promising approach to kidney transplantation	183
A puzzling renal Fanconi syndrome	90
Donor-derived membranous nephropathy	76
Correction to: Accelerated versus watchful waiting strategy of kidney replacement therapy for acute kidney injury: a systematic review and meta-analysis of randomized clinical trials	70
Risk factors for acute kidney injury and kidney relapse in patients with lupus podocytopathy	58
ECOSBot: a multicenter validation pilot study of a generative AI tool for OSCE-based nephrology training	57
But how green is it actually? Calculating the environmental footprint of kidney care environmental optimizations within haemodialysis	55
Impact of the COVID pandemic on vascular access creation for haemodialysis in 16 Spanish haemodialysis centres	54
Toward acid- and heparin-free dialysis: the regional anticoagulation approach	52
Differentiating primary and secondary FSGS using non-invasive urine biomarkers	46
Circulating miR-129-3p in combination with clinical factors predicts vascular calcification in hemodialysis patients	46
Bilateral nephrectomy in autosomal dominant polycystic kidney disease patients before or after renal transplantation: data from a retrospective cohort study	44
Correction to: Recognition of intraglomerular histological features with deep learning in protocol transplant biopsies and their association with kidney function and prognosis	43
Association between frailty and bone health in early-stage chronic kidney disease: a study from the population-based CARTaGENE cohort	43
Can exercise improve outcomes for frail haemodialysis patients?	40
Performance of the race-free CKD-EPI creatinine-based eGFR equation in a Danish cohort with measured GFR	40
Causal relationships between immune cell phenotypes and primary glomerular diseases: genetic evidence from bidirectional Mendelian randomization study	39
Non-invasive assessment of IgA nephropathy severity with [18F]AlF-NOTA-FAPI-04 PET/CT imaging	38
Cerebral blood flow following successful living kidney transplantation: the VINTAGE study	38
Risk factors for steroid-induced osteonecrosis of the femoral head in children with immune kidney disease	37
Plant-based diets for CKD patients: fascinating, trendy, but feasible? A green nephrology perspective	37
The “Leicester, Leicestershire, and RUtland Chronic Kidney Disease Integrated Care Delivery Project” (LUCID) programme update: the impact on novel kidney therapies	37
Galectin-3 as a prognostic biomarker in haemodialysis patients with preserved or mildly reduced ejection fraction	36
Clinically meaningful eGFR slope as a surrogate endpoint differs across CKD stages and slope evaluation periods: the CKD-JAC study	36
Making Use of Avacopan in Clinical Practice	36

Ten tips on performing economic evaluation in kidney disease	36
Novel eGFR equations and cardiovascular outcomes in a multiethnic Asian cohort	35
Machine learning models for predicting acute kidney injury: a systematic review and critical appraisal	35
Microvascular perfusion, perfused boundary region and glycocalyx shedding in patients with autosomal dominant polycystic kidney disease: results from the GlycoScore III study	34
Probability of chronic kidney disease and associated risk factors in Chinese adults: a cross-sectional study of 9 million Chinese adults in the Meinian Onehealth screening survey	33
Biomarkers in clinical epidemiology studies	33
The spectrum of diseases, genetic landscape and new mutation sites of hereditary cystic kidney disease	32
Complement activation in anti-glomerular basement membrane disease before and after treatment with imlifidase	32
Alleviating symptoms in patients undergoing long-term hemodialysis: a focus on chronic kidney disease-associated pruritus	32
Meet and greet but avoid the heat: a reflection on the carbon footprint of congresses prompted by ERA2023	32
Safety and efficacy of glucagon-like peptide-1 receptor agonists among kidney transplant recipients: a systematic review and meta-analysis	31
Obinutuzumab treatment for membranous nephropathy: effectiveness and safety concerns during the COVID-19 pandemic	31
Recent advances in pathogenetic concepts and disease modeling of IgA nephropathy	31
Standardization of serum creatinine is essential for accurate use of unbiased estimated GFR equations: evidence from three cohorts matched on renal function	31
Efficacy and safety of telitacicept, a BLyS/APRIL dual inhibitor, in the treatment of IgA nephropathy: a retrospective case–control study	31
The use of SGLT2 inhibitors and GLP-1 receptor agonists in older patients: a debate on approaches in CKD and non-CKD populations	30
Informal caregiver burden in dialysis care and how it relates to patients’ health-related quality of life and symptoms	30
Use of eHealth and remote patient monitoring: a tool to support home dialysis patients, with an emphasis on peritoneal dialysis	29
Interaction of general obesity and abdominal obesity with frailty in patients with chronic kidney disease: a nationally representative analysis	29
Complications on the feeding artery after an arterio-venous fistula closure in patients after kidney transplantation – a national cohort study	29
More dissimilarities than affinities between DNAJB11-PKD and ADPKD	29
The effect of sevelamer on serum calcification propensity in patients with chronic kidney disease: the results of a multicentre, double-blind, placebo-controlled, randomized clinical trial	29
Ten tips on how to manage kidney health in migrants and refugees	29
International validation of a pre-transplant risk assessment tool for graft survival in pediatric kidney transplant recipients	28
Denosumab-induced hypocalcemia in patients treated with dialysis: an avoidable complication?	28
Cerebral white matter injury in haemodialysis patients: a cross-sectional tract-based spatial statistics and fixel-based analysis	28
Efficacy and safety of belimumab in refractory and newly diagnosed active lupus nephritis patients: a real-world observational study	27
Troponin I is an independent predictor of cardiovascular events and mortality in haemodialysis patients	27
Association between beta-blocker utilization and heart failure mortality in the peritoneal dialysis population: a cohort study	26
Self-limited, sodium-dependent osmotic diuresis causes polyuria after living donor kidney transplantation	26
Glycemic control and complications in hemodialysis patients: the TURK-HEMODIAB STUDY	26
The Many Faces of NELL1 MN	25
The impact of gender on the risk of cardiovascular events in older adults with advanced chronic kidney disease	25
Effect of renal denervation on glucose metabolism in hypertensive patients with and without chronic kidney disease	25
Treatment of primary hyperoxaluria type 1	25
Kidney Donor Profile Index and allograft outcomes: interactive effects of estimated post-transplant survival score and ischaemic time	25
Fibrillary glomerulonephritis: an observational study of clinical-pathological features and outcomes in patients from a multi-institutional cohort	25
Soluble urokinase plasminogen activator receptor and decline in kidney function among patients without kidney disease	24
Introduction to new CKJ section: In Context – in collaboration with YNP	24
The integrated care model: facilitating initiation of or transition to home dialysis	24
Acute kidney injury due to inhalation of metal fumes	24
Addressing cognitive impairment in peritoneal dialysis: a systematic review and meta-analysis of prevalence, risk factors, and outcomes	24
Kidney hemodynamic effects of sodium-glucose cotransporter 2 inhibitors in diabetes: physiology and clinical implications	24
Multiomic profiling of new-onset kidney function decline: insights from the STANISLAS study cohort with a 20-year follow-up	24
Strategies to prevent SARS-CoV-2 transmission in hemodialysis centres across Europe—lessons for the future	23
Evolving spectrum but persistent high mortality of COVID-19 among patients on kidney replacement therapy in the vaccine era: the Spanish COVID-19 KRT Registry	23
A small circulating miRNAs signature predicts mortality and adverse cardiovascular outcomes in chronic hemodialysis patients	23
Coordinating efforts to optimize next-generation kidney replacement therapies: the European Kidney Health Alliance Work Group ‘Breakthrough Innovation’	23
Novel loss-of-function mutations in TNFAIP3 gene in patients with lupus nephritis	23
Effects of anti-inflammatory agents on clinical outcomes in people with chronic kidney disease: a systematic review and meta-analysis of randomized control trials	23

Renal function is highly associated with podiatric risk in diabetic patients	22
The role of low health literacy in shared treatment decision-making in patients with kidney failure	22
Visit-to-visit variability in blood pressure and kidney disease progression in IgA nephropathy	22
Association between cause of kidney failure and fracture incidence in a national US dialysis population cohort study	22
Cardiometabolic protein expression levels and pathways associated with kidney function decline in older European adults with advanced kidney disease	22
Lower serum magnesium levels are associated with a higher risk of fractures and vascular calcifications in hemodialysis patients	21
Genetic and clinical characterization of familial renal glucosuria	21
Comparison of safety and outcomes related to remdesivir treatment among dialysis patients hospitalized with COVID-19	21
Urinary peptide signature distinguishes autosomal recessive polycystic kidney disease from other causes of chronic kidney disease	20
Epidemiological risk factors for acute kidney injury outcomes in hospitalized adult patients: a multicenter cohort study	20
Ultrafiltration rate and mortality in patients undergoing extended-hours haemodialysis	20
Estimating 24-hour urine phosphate excretion from spot urine	20
Wasp stings and plasma exchange	20
Should we enlarge the indication for kidney biopsy in patients with diabetes? The pro part	20
Elevated RHAMM as a biomarker for predicting diabetic kidney disease in patients with type 2 diabetes	20
Understanding and targeting senescence in kidney disease	20
The burden of hyperkalaemia in chronic kidney disease: a systematic literature review	20
A 20-year follow-up study of identical twin sisters with immunoglobulin A nephropathy	20
Association of deprivation and its individual domains on outcomes in people with chronic kidney disease	19
Renal outcomes in immunoglobulin A nephropathy following COVID-19 vaccination: a retrospective cohort study	19
Valvular heart disease in patients on kidney replacement therapy: “opening Pandora's box”	19
RNA therapeutics in kidney diseases: prospects and current status	19
Remote management of anaemia in patients with end-stage kidney disease using a wearable, non-invasive sensor	19
Predicting prognosis in ANCA-associated vasculitis with kidney involvement	19
Novel NUP160 mutations related to simultaneous congenital nephropathy and ovarian insufficiency	19
Induction therapy for class I/II lupus nephritis with glucocorticoid monotherapy associates with higher relapse and poorer kidney outcomes	19
Correction to: Decongestion in patients with advanced chronic kidney disease coexisting with heart failure	19
Prevalence, awareness, treatment, and control of hypertension in community-dwelling older adults with chronic kidney disease: the Irish longitudinal study on ageing	19
Endothelin receptor antagonists in diabetic and non-diabetic chronic kidney disease	18
Potassium management and heart failure: a nephrologist's perspective	18
Partnering with patients and caregivers to enrich research and care in kidney disease: values and strategies	18
Sodium glucose co-transporter 2 inhibitors in the treatment of glomerular diseases: a CKJ controversy	18
Valvular calcification in chronic kidney disease: new insights from recent clinical and preclinical studies	18
Mucosal-associated invariant T-cells and the gut-kidney axis: a review	18
Probiotics for kidney disease	18
From electronic health records to clinical management systems: how the digital transformation can support healthcare services	18
Personalizing electrolytes in the dialysis prescription: what, why and how?	18
Implementing a model of integrated CKD management between primary and secondary care	18
What to do with key cardiovascular drugs when kidney function worsens?	17
The impacts of hypoxia-inducible factor stabilizers on laboratory parameters and clinical outcomes in chronic kidney disease patients with renal anemia: a systematic review and meta-analysis	17
Genetic testing in focal segmental glomerulosclerosis: in whom and when?	17
Automating kidney transplant rejection diagnosis: a simple solution for a complex problem?	17
Long-term effect of increasing water intake on repeated self-assessed health-related quality of life (HRQoL) in autosomal dominant polycystic kidney disease	17
Urgent initiation of hemodialysis versus peritoneal dialysis in severe hyperkalemia: a prospective study	17
Humoral and cellular immunogenicity of a fourth dose BNT162b2 in children with chronic kidney diseases	17
Integrating multiple kidney function markers to predict all-cause and cardiovascular disease mortality: prospective analysis of 366 758 UK Biobank participants	17
Leukopenia in autosomal dominant polycystic kidney disease: a single-center cohort of kidney transplant candidates with post-transplantation follow-up	17
Fatigue across different chronic kidney disease populations: experiences and needs of patients	17
Dapagliflozin in chronic kidney disease: cost-effectiveness beyond the DAPA-CKD trial	17
Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal Association	17
Induction immunosuppression and outcome in kidney transplant recipients with early COVID-19 after transplantation	17
Novel equations for estimating intraperitoneal pressure among peritoneal dialysis patients	17
Designing qualitative research with value in the clinical and epidemiological context: what, why and how	17
Collagen type III formation but not degradation is associated with risk of kidney disease progression and mortality after acute kidney injury	16
Rituximab as a first-line therapy in children with new-onset idiopathic nephrotic syndrome	16
Individualized everolimus treatment for tuberous sclerosis-related angiomyolipoma promotes treatment adherence and response	16
Prospective evaluation of CAR-T cell therapy-related proteinuria and kidney dysfunction	16
Prescription patterns of sodium and calcium polystyrene sulfonate in patients with hyperkalemia and chronic kidney disease receiving RAAS inhibitors	16
Correction to: Clinical implications of mineralocorticoid receptor overactivation	16
Integrative analysis of the association between circadian rhythm and lupus nephritis	16
Ageing meets kidney disease	16
Dynamic prediction of kidney allograft and patient survival using post-transplant estimated glomerular filtration rate trajectory	16
Three decades of CKD due to diabetes mellitus type 2 in China, with projections of disease burden from 2022 to 2036: a systematic analysis for the Global Burden of Disease Study 2021	16
Telitacicept versus mycophenolate mofetil in IgA nephropathy: a real-world comparative study of efficacy, renal outcomes and safety	16
Current practices in prevention, screening, and treatment of diabetes in kidney transplant recipients: European survey highlights from the ERA DESCARTES Working Group	16
The effect of COVID-19 vaccination on kidney function and HLA antibody formation in patients with end-stage kidney disease and on kidney replacement treatment	16
The role of blood purification therapies in the treatment of chronic kidney disease–associated pruritus: a systematic review	16
Anticoagulation in patients with end-stage kidney disease and atrial fibrillation: a national population-based study	15
New aspects in cardiorenal syndrome and HFpEF	15
Liver safety of tolvaptan in patients with autosomal dominant polycystic kidney disease: interim data from a post-authorization safety study	15
New and old GFR equations: a European perspective	15
Multiparametric MRI: can we assess renal function differently?	15
National Unified Renal Translational Research Enterprise: Idiopathic Nephrotic Syndrome (NURTuRE-INS) study	15
Differences in association between hypoalbuminaemia and mortality among younger versus older patients on haemodialysis	15
Machine learning models for mortality prediction in critically ill patients with acute pancreatitis–associated acute kidney injury	15
Cancer risks in people on dialysis and kidney transplant recipients: a Catalan cohort study, 2003–21	15
Decoy receptors as biomarkers for exploring aetiology and designing new therapies	15
Renal involvement is frequent in adults with primary mitochondrial disorders: an observational study	15
Anti-phospholipid antibodies nephropathy is associated with an increased risk of kidney failure: a systematic literature review and meta-analysis	15
Urinary soluble PD-1 as a biomarker of checkpoint inhibitor-induced acute tubulointerstitial nephritis	15

Management of hypertension in patients with cancer: challenges and considerations	14
Mortality associated with the COVID-19 pandemic in the Swiss dialysis population beyond SARS-CoV-2 infection	14
Asymmetric dimethylarginine and citrulline are risk factors for cardiovascular disease independently of both estimated and measured GFR	14
Prophylactic proton pump inhibitor usage and new-onset acute kidney injury in critically ill patients: a retrospective analysis	14
Defining diagnostic trajectories in patients with podocytopathies	14
Reply to ‘Depression and clinical outcomes in CKD: do anti-depressants play a role? (EQUAL Study)’	14
Association of albuminuria with incident atrial fibrillation in healthy older adults	14
Nafamostat mesylate has advantages as an anticoagulant for patients undergoing maintenance hemodialysis with conjunctival bleeding	14
Hyponatremia and the risk of sepsis in the setting of chronic kidney disease not on dialysis	14
Personalized peritoneal dialysis prescription—beyond clinical or analytical values	14
Prospective study of the effect of rituximab on kidney function in membranous nephropathy	14
Correction to: Moving on obesity treatment in CKD: inertia is unjustified	14
COVID-19 among kidney transplant recipients: evaluating risk factors during the initial phase of the pandemic	14
Association between serum short-chain fatty acid levels and the risk of all-cause and cardiovascular disease mortality in Chinese patients undergoing maintenance hemodialysis: a retrospective cohort s	14
Artificial intelligence to guide rituximab therapy in patients with phospholipase A2 receptor–associated membranous nephropathy	13
Epigenetic mechanisms of salt-sensitive hypertension	13
Considering the utility of urinary amino acids for early identification of non-diabetic chronic kidney disease	13
Long-term outcomes of adults with FSGS in the German Chronic Kidney Disease cohort	13
Cardiovascular risk prediction in hemodialysis patients using the triglyceride-glucose index: a multicenter prospective cohort study	13
Synergistic effect of teclistamab with PD-1 inhibition: a case of acute interstitial nephritis with dual immunotherapy	13
Triglycerides–glucose index and the risk of cardiovascular events in persons with non-diabetic chronic kidney disease	13
Trunk muscle quality and quantity are associated with renal volume in nondiabetic people	13
Malignancies and glomerulonephritis: when to suspect and when to screen?	13
Real-world usage of Chronic Kidney Disease – Mineral Bone Disorder (CKD–MBD) biomarkers in nephrology practices	13
Time-averaged concentration estimation of uraemic toxins with different removal kinetics: a novel approach based on intradialytic spent dialysate measurements	13
The effect of a ketogenic diet on weight loss in CKD: a randomized controlled trial in obese stage G1–3a CKD patients	13
New trials in resistant hypertension: mixed blessing stories	13
Social deprivation as a key driver of spatial disparities in end-stage kidney disease incidence	13
Longitudinal serum bicarbonate and mortality risk in older patients with advanced chronic kidney disease: analyses from the EQUAL cohort	13
Safety and efficacy of pre-exposure prophylaxis with tixagevimab/cilgavimab (Evusheld) in patients with glomerular diseases who received rituximab	13
The elevation of the anion gap in steady state chronic kidney disease may be less prominent than generally accepted	13
Performance of an interstitial glucose monitoring device in patients with type 1 diabetes during haemodialysis	12
Kidney–placenta crosstalk in health and disease	12
Urinary microvesicles: a window into the kidney	12
Are we ready for an adipocentric approach in people living with type 2 diabetes and chronic kidney disease?	12
Incremental versus conventional haemodialysis in end-stage kidney disease: a systematic review and meta-analysis	12
Antibody titers against SARS-CoV-2 spike protein 6 months after a third BNT162b2 vaccine in chronic hemodialysis patients	12
A review of supportive care for older people with advanced chronic kidney disease	12
Anti-nephrin antibody: a potential biomarker of minimal change disease	12
Twenty-four-hour proteinuria levels are associated with adverse pregnancy outcomes among women with CKD	12
Sodium–glucose co-transporter inhibitors, refractory hypomagnesaemia and recurrent genital mycotic infections	12
Cystatin C–based estimated GFR performs best in identifying individuals with poorer survival in an unselected Chinese population: results from the China Health and Retirement Longitudinal Study (CHARL	12
Risk factors for major bleeding in patients with atrial fibrillation and CKD G3–G5D on oral anticoagulants	12
Reply to ‘Stability and compatibility of antibiotics in PD solutions—call for including antibiotics for drug-resistant infections’	12
Hypoxia-inducible factor prolyl hydroxylase inhibitors in kidney transplant recipients	12
Congestion as a crucial factor determining albuminuria in patients with cardiorenal disease	12
2025 Update on resistant hypertension in CKD: where do we stand and where do we go?	12
Mechanisms and treatment of obesity-related hypertension—Part 2: Treatments	12
Incidence and prognosis of acute kidney injury versus acute kidney disease among 71 041 inpatients	12
Immobilization-associated hypercalcaemia in patients with malignancy in the hospital setting	12
Lung ultrasonography performed by nephrologist: COVID-19 as an opportunity to reveal ultrasound's full potential and usefulness in the dialysis room	12
Kidney replacement therapy patients with COVID-19 in the vaccine era: what do we need to know?	12
Quantifying the potential contribution of drugs to the occurrence of acute kidney injury in patients with chronic kidney disease	11
Estimation of glomerular filtration rate in cardiorenal patients: a step forward	11
International Variations in Chronic Kidney Disease Patients’ Pain Experience and its Management	11
Chronic kidney disease duration and suicide risk among maintenance hemodialysis patients in China	11
Trajectories of urea‑to‑creatinine ratio and risk of clinical outcomes in survivors of acute kidney disease: a population-based study	11
Prophylactic ultra-low dose rituximab to maintain remission in relapsing adult minimal change disease	11
ERA Registry Figure of the month Expected remaining years of life for dialysis and kidney transplant patients	11
Uraemic burden index: a novel predictor of pre-emptive kidney transplant outcome	11
Efficacy and safety of finerenone in IgA nephropathy: an observational multicentre study	11
The long-term benefits of early intensive therapy in chronic diseases—the legacy effect	11
Correction to: Using artificial intelligence to predict mortality in AKI patients: a systematic review/meta-analysis	11
Ionized and total magnesium levels in patients with chronic kidney disease: associated factors and outcomes	11
Kidney Failure Risk Equation performance according to the etiology of chronic kidney disease in the CKD-CAREMEAU cohort	11
Matrix Gla protein polymorphism rs1800802 is associated with atheroma plaque progression and with cardiovascular events in a chronic kidney disease cohort	11
Correction to: Spatially resolved transcriptomic profiling for glomerular and tubulointerstitial gene expression in C3 glomerulopathy	11
Healthy aging and aging-related kidney diseases: lessons from centenarians	11
Circulating metabolites associated with kidney function decline and incident CKD: a multi-platform population-based study	11
Association of urinary albumin:creatinine ratio with incident frailty in older populations	11
Real-world analysis of the impact of finerenone on estimated glomerular filtration rate and albuminuria in patients with diabetic kidney disease	11
Disturbance in the potential cardiovascular–bone–skeletal muscle axis and morbidity and mortality in patients undergoing haemodialysis: the Q-Cohort Study	11
Albuminuria after induction treatment and kidney prognosis in ANCA-associated glomerulonephritis	11
Should we continue to use renin–angiotensin–aldosterone system blockers in patients with COVID-19?	10
Compound heterozygous variants of ANKFY1 in a child with infantile-onset proteinuria and movement disorder	10
The impact of mild and moderate COVID-19 infection on the progression of kidney dysfunction in patients with IgA nephropathy	10
Bone mineral density after exercise training in patients with chronic kidney disease stages 3 to 5: a sub-study of RENEXC—a randomized controlled trial	10
C5a receptor inhibitor avacopan in immunoglobulin A nephropathy—an open-label pilot study	10
Qualitative approach to better understand the trajectory of patients with early and moderate stage CKD	10
Rationale and design of CONTINUITY: a Phase 4 randomized controlled trial of continued post-discharge sodium zirconium cyclosilicate treatment versus standard of care for hyperkalemia in chronic kidne	10
Trial design of the MOTheR HDx study: a multicenter, open-label, prospective, randomized study to explore the morbidity and mortality in patients dialyzed with the Theranova HDx in comparison with onl	10
Development and validation of a measure to assess patient experience of needling of arteriovenous fistulas or grafts for haemodialysis access: the NPREM	10
The diagnostic accuracy of ultrasound and genomic tests for the diagnosis of autosomal-dominant polycystic kidney disease: a systematic mapping review	10
The risk of CKD progression remains high in patients treated with ACE inhibitors and ARBs, MRAs and SGLT2 inhibitors. Have we already achieved the therapeutic ceiling in CKD? (The CON part)	10
Ten tips to teach learners to love nephrology (and recruit the next generation)	10
History of creatinine clearance: tribute to a forerunner	10
Association of metabolic acidosis with fractures, falls, protein-calorie malnutrition and failure to thrive in patients with chronic kidney disease	10
31P-MRS, molecular level imaging for assessing muscular mitochondrial dysfunction in chronic kidney disease	10
Histologic characterization and risk factors for persistent albuminuria in adolescents in a region of highly prevalent end-stage renal failure of unknown origin	10
Who killed Bruce Lee? The hyponatraemia hypothesis	10
Peritoneal dialysis for acute kidney injury: back on the front-line	10
Activation of the inflammasome and pyroptosis cascade in podocytes of patients with minimal change disease	10
A treasure from a barren island: the discovery of rapamycin	10
A pre-transplantation risk assessment tool for graft survival in Dutch pediatric kidney recipients	10
Long-term evaluation of the timing of corticosteroid therapy in an IgA nephropathy cohort	10